Prostate cancer Board decisions

The Veteran's prostate cancer is rated at 40 percent, and the Board found no evidence to warrant a higher rating.

The Veteran's digestive disorder, including Barrett's esophagus and GERD, is not service-connected. The Veteran's prostate cancer residuals are granted a 40 percent rating since May 1, 2017.

The Board has remanded the cases for further development and examination, including a new VA examination to assess the Veteran's prostate cancer residuals and vertigo disorder. The issues of whether the reduction was proper and whether a higher rating is warranted are also being addressed.

The Veteran's TDIU claim was denied as his service-connected disabilities do not render him unable to secure or follow a substantially gainful occupation, and there were no exceptional factors from the service-connected disabilities that precluded him from obtaining and maintaining such employment.

The Veteran's service connection claim for prostate cancer, which he claims is related to his in-service exposure to Agent Orange, has been granted. The Board found that the Veteran served within 12 nautical miles of Vietnam and thus had presumptive exposure to herbicide agents.

The Board has remanded the claims for service connection for various disabilities, including a sleep disability and hearing loss. The Veteran is seeking service connection for these conditions based on exposure to herbicide agents during service.

The Board has denied the Veteran's claims for service connection for Type II Diabetes Mellitus, Hypertension, Prostate Cancer, Erectile Dysfunction, and Incontinence. The claim of service connection for a lumbar spine disability is remanded.

The Veteran's appeals regarding his adjustment disorder with anxiety and depressed mood, prostate cancer reduction from 100% to 40%, prostate cancer rating higher than 40%, and TDIU prior to January 22, 2016 are all remanded for additional development.

The Board has remanded the case due to insufficient reasoning in its decision regarding whether the Veteran's pancreatitis is secondary to his service-connected diabetes mellitus, type II. An addendum opinion is needed from a clinician to address this issue.

The Board has decided that the Veteran's prostate cancer residuals do not meet the criteria for compensation under 38 U.S.C. § 1151, and has remanded the service connection claim for asthma.

The Board has remanded the case due to insufficient development of evidence regarding the Veteran's exposure to herbicide agents and radar radiation during service, as well as his treatment records from a private cancer center. The AOJ is instructed to verify these exposures and obtain any relevant medical records.

The Board has remanded the case due to a failure of the duty to assist and an error in reliance on the October 2018 VA medical opinion. The Veteran's service treatment records need to be obtained, and an addendum opinion is required from the VA examiner.

The Veteran's prostate cancer residuals are rated at 60 percent from February 1, 2015 to October 9, 2019. The skin disorder claim is denied as the current diagnoses do not support a finding of service connection.

The Board denied service connection for prostate cancer, including as due to herbicide exposure, finding no evidence of in-service exposure or a link between the condition and service.

The Board has remanded the case due to inadequate efforts by the AOJ in obtaining radiation exposure information related to the Veteran's periods of service, including his reserve and active duty. The AOJ is instructed to make a new request for this information.

The Veteran's prostate cancer residuals, including urinary leakage and frequency issues, are now rated at 40 percent effective from August 6, 2014.

The Board has granted service connection for prostate cancer and diabetes mellitus, both of which are presumed to be due to exposure to herbicides in Thailand. The left hip disability is denied as there is no evidence of a current disability within one year post-service.

The Board has granted service connection for cataract of the left eye and remanded prostate cancer due to exposure to herbicide agents.

The Board has granted service connection for the Veteran's residuals of prostate cancer, finding that it is secondary to his service-connected chronic prostatitis.

The Veteran's claim for service connection for prostate cancer, including as due to ionizing radiation exposure is denied. The Veteran's claim for an initial compensable rating for bilateral hearing loss prior to August 12, 2015 and a rating in excess of 30 percent for bilateral hearing loss from January 23, 2020 to the present are also denied.